CoChat

Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis

Open access

The DOI matches its Crossref record; 113 of the 114 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Type II focal cortical dysplasia (FCD) is a neuropathological entity characterised by cortical dyslamination with the presence of dysmorphic neurons only (FCDIIA) or the presence of both dysmorphic neurons and balloon cells (FCDIIB). The year 2021 marks the 50th anniversary of the recognition of FCD as a cause of drug resistant epilepsy, and it is now the most common reason for epilepsy surgery. The causes of FCD remained unknown until relatively recently. The study of resected human FCD tissue using novel genomic technologies has led to remarkable advances in understanding the genetic basis of FCD. Mechanistic parallels have emerged between these non-neoplastic lesions and neoplastic disorders of cell growth and differentiation, especially through perturbations of the mammalian target of rapamycin (mTOR) signalling pathway. This narrative review presents the advances through which the aetiology of FCDII has been elucidated in chronological order, from recognition of an association between FCD and the mTOR pathway to the identification of somatic mosaicism within FCD tissue. We discuss the role of a two-hit mechanism, highlight current challenges and future directions in detecting somatic mosaicism in brain and discuss how knowledge of FCD may inform novel precision treatments of these focal epileptogenic malformations of human cortical development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms23031344

Cites

113 of 114 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The mechanistic target of rapamycin (mTOR) signalling pathway. Pathogenic germline or somatic variants are identified in the coloured components. Specifically, PTEN and S6 are associated with hemimegalencephaly (HME) only, while the rest are associated with both focal cortical dysplasia (FCD) and HME.
Figure 1 The mechanistic target of rapamycin (mTOR) signalling pathway. Pathogenic germline or somatic variants are identified in the coloured components. Specifically, PTEN and S6 are associated with hemimegalencephaly (HME) only, while the rest are associated with both focal cortical dysplasia (FCD) and HME.CC BY · PubMed Central
Figure 2 Illustration of two-hit mechanism in cortical dysplasia. In the unaffected cortex, a heterozygous germline DEPDC5 variant is present in all cells but does not cause “visible” lesion at MRI. In the lesional cortex, it is hypothesised that a postzygotic somatic DEPDC5 variant (or variant in another mTOR pathway genes) occurred in a subset of cells, leading to localised brain lesion.
Figure 2 Illustration of two-hit mechanism in cortical dysplasia. In the unaffected cortex, a heterozygous germline DEPDC5 variant is present in all cells but does not cause “visible” lesion at MRI. In the lesional cortex, it is hypothesised that a postzygotic somatic DEPDC5 variant (or variant in another mTOR pathway genes) occurred in a subset of cells, leading to localised brain lesion.CC BY · PubMed Central
Figure 3 Focal cortical dysplasia (FCD) and hemimegalencephaly (HME) as a continuum of cortical dysplasias caused by commonly shared genetic variants with different mutation load. In small FCD, a small subset of cells is affected, which contribute to the small mutation load and restricted lesion. In HME, a larger number of cells carry the somatic variant, resulting in higher mutation load and a more diffuse lesion. It is important to acknowledge that there are even smaller lesions including presumed MRI-negative lesions within this spectrum, associated with ultra-low mutation load.
Figure 3 Focal cortical dysplasia (FCD) and hemimegalencephaly (HME) as a continuum of cortical dysplasias caused by commonly shared genetic variants with different mutation load. In small FCD, a small subset of cells is affected, which contribute to the small mutation load and restricted lesion. In HME, a larger number of cells carry the somatic variant, resulting in higher mutation load and a more diffuse lesion. It is important to acknowledge that there are even smaller lesions including presumed MRI-negative lesions within this spectrum, associated with ultra-low mutation load.CC BY · PubMed Central
Figure 4 Cortical development and hypothetical occurrence of somatic variant in a subset of brain cells during neurogenesis. During cortical development, neuroepithelial cells undergo symmetric division to generate more progenitors. Neuroepithelial cells then convert into radial glia, which are able to divide asymmetrically to generate intermediate progenitor cells, migrating neurons, and more radial glia. Intermediate progenitor cells can divide symmetrically to generate clones of neurons. Neurons migrate radially along radial glia to the designated cortical layer to become mature neurons. Radial glia also give rise to outer radial glia, which also have the potential to undergo asymmetric division. In a hypothetical scenario, a somatic variant may occur in intermediate progenitor cells during the process of proliferation (red). These variant-carrying intermediate progenitor cells give rise to neurons that similarly harbour the variant. Neurons of a different clonal origin can continue to be produced normally without somatic variant (blue). This process results in a mixture of brain cells in which only a proportion of cells may carry the somatic variant. Furthermore, interneurons migrate tangentially from the ganglionic eminence (not shown), astrocytes, oligodendrocytes and microglial cells further complicate the clonal diversity in any given cortical region.
Figure 4 Cortical development and hypothetical occurrence of somatic variant in a subset of brain cells during neurogenesis. During cortical development, neuroepithelial cells undergo symmetric division to generate more progenitors. Neuroepithelial cells then convert into radial glia, which are able to divide asymmetrically to generate intermediate progenitor cells, migrating neurons, and more radial glia. Intermediate progenitor cells can divide symmetrically to generate clones of neurons. Neurons migrate radially along radial glia to the designated cortical layer to become mature neurons. Radial glia also give rise to outer radial glia, which also have the potential to undergo asymmetric division. In a hypothetical scenario, a somatic variant may occur in intermediate progenitor cells during the process of proliferation (red). These variant-carrying intermediate progenitor cells give rise to neurons that similarly harbour the variant. Neurons of a different clonal origin can continue to be produced normally without somatic variant (blue). This process results in a mixture of brain cells in which only a proportion of cells may carry the somatic variant. Furthermore, interneurons migrate tangentially from the ganglionic eminence (not shown), astrocytes, oligodendrocytes and microglial cells further complicate the clonal diversity in any given cortical region.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 114 references

Research works printed but not linked: 2

  1. Horsley, 1886, Brain Surgery, Br. Med. J., 2, 670
  2. Stephenson, S.E.M., Owens, H.G., Richards, K.L., Lee, W.S., D’Arcy, C., Barton, S., Mandelstam, S.A., Maixner, W.J., MacGregor, D., and Petrou, S. (2019). Dysmorphic neuron density is highest in the centre of epileptogenic cortical tubers. bioRxiv, 621607.

Cited by

See all 46

Metadata

Authors
Lee, W. S., Baldassari, S., Stephenson, S. E. M., Lockhart, P. J., Baulac, S., & Leventer, R. J.
Affiliations
  • The University of Melbourne (AU)
  • Centre National de la Recherche Scientifique (FR)
  • Royal Children's Hospital (AU)
Corresponding author
  • Baulac, Stéphanie
  • Leventer, Richard J.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2022-01-25
Volume
23
Issue
3
Pages
1344
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4210390266
Cited by
45
References
114
Citations by year
2026: 6 · 2025: 11 · 2024: 8 · 2023: 13 · 2022: 7
FWCI
1.67
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
Funders
  • Medical Research Council
  • National Health and Medical Research Council (1161549)
  • H2020 European Research Council (682345)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
  • Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
focal cortical dysplasia type II, mTOR signaling, epileptogenesis, drug-resistant epilepsy, somatic mosaicism, two-hit mechanism, balloon cells, dysmorphic neurons, human brain tissue
MeSH terms
Drug Resistant Epilepsy, Brain, Epilepsy, Humans, Mutation, Neurons, Signal Transduction, Malformations of Cortical Development, TOR Serine-Threonine Kinases, Malformations of Cortical Development, Group I

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis. https://app.cochat.ai/papers/10.3390/ijms23031344
The paper
Lee, W. S., Baldassari, S., Stephenson, S. E. M., Lockhart, P. J., Baulac, S., & Leventer, R. J. (2022). Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms23031344

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.